Plexus Corp logo

Plexus Corp(PLXS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
3-STAR RATING
PASS
LAST CLOSE
$208.46
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for PLXS

11/13/2026: PLXS (3-star) is currently NOT-A-BUY. Pass it for now.

Plexus Corp is a prominent provider of complex product realization services, specializing in engineering, manufacturing, and support for high-regulation sectors like healthcare and industrial technology. The company distinguishes itself through a focus on high-complexity, high-reliability products rather than high-volume consumer goods, which has historically helped it build deep relationships with long-term customers. While it has a leading position in its niche, the stock is subject to industrial cyclicality and customer concentration risks. Plexus does not pay a dividend, making it better suited for growth-oriented investors looking for exposure to the medical and industrial automation sectors. Key developments to monitor include customer program wins and the progress of its manufacturing expansion in the Americas.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitPlexus targets high-growth segments in medical and industrial technology which provides a long runway for expansion.
Momentum investorStrong fit while signal remains positiveThe stock often trends with successful contract wins and positive earnings momentum in the industrial sector.
Value investorMixed fitValuation often tracks closely with industrial manufacturing cycles, making entry point timing important.
Dividend investorWeak fitPlexus does not pay a dividend, prioritizing internal growth reinvestment.
Low-risk investorMixed fitWhile established, the stock is subject to industrial cyclicality and customer concentration risks.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock can experience swings based on quarterly earnings results and general industrial sector sentiment.
Valuation riskMediumMarket expectations for growth in medical and aerospace can lead to premium pricing during sector rallies.
Competition risk (EMS market competition)Medium / highPlexus faces intense competition from both massive global EMS players and specialized regional firms.
Business qualityMediumThe business model relies on high-complexity, high-regulation products which requires significant engineering competence.
Dividend incomeLow / noneIncome-focused investors will find no yield here as the company reinvests all free cash flow.
Execution riskMediumDelivering complex products on time for regulated industries requires flawless manufacturing and supply chain coordination.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 5.56B USD
Price to earnings Ratio 28.13
1Y Target Price 307.8
Price to earnings Ratio 28.13
1Y Target Price 307.8
Volume (30-day avg) 313.9K shares
Beta 0.96
52 Weeks Range 132.03 - 307.06
Updated Date 11/14/2026
52 Weeks Range 132.03 - 307.06
Updated Date 11/14/2026
Dividends yield (FY) -
Basic EPS (TTM) 7.41

Sector & Industry Intelligence

Sector

Technology

Caution
Sentiment
Near Bearish
Momentum
Rapid Breadth Deterioration
BUY participation
30.1%
Active BUY / eligible
37 / 123
30-Day BUY Count Change
-42
Market state
Weak Bullish / Near Bearish

BUY participation is falling rapidly, suggesting elevated market vulnerability.

Industry

Electronic Components

BUY participation
0.0%
Active BUY / eligible
0 / 11
30-Day BUY Count Change
-6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 24.48%
Avg. Invested days 49
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
PLXS receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
PLXS has moderate overall fundamentals (3 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2026 versus FY2025, solid earnings growth (+17.1%) and solid revenue growth (+23.1%) are partially offset by weak cash generation (FCF margin -0.6%), soft profitability (net margin 4.1%), modest insider ownership of 1.59%.

Financial Health Rating

★★★★★
PLXS's financial health is supported by moderate efficiency, including operating-expense and cost-of-revenue discipline (opex 4.8% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Revenue growth is PLXS's strongest growth driver at +23.1% FY2026 versus FY2025 (solid, 4 stars). By comparison, earnings growth (+17.1%, solid) is also solid, while free-cash-flow growth (-118.8%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 102.4% and approximately 98.5% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 1.59% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 16.37%
Vanguard Portfolio Management, LLC 7.92%
Disciplined Growth Investors Inc 5.41%
Vanguard Capital Management, LLC 4.53%
American Century Companies Inc 4.44%

Unit Economics (Per $1K Revenue)

★★★★★
PLXS generates approximately $101 of gross profit, $53 of operating income, and $-6 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Negative free cash flow explains the 1-star rating, with weak cash conversion and moderate capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 17.63%

Quantitative Style Profile

★★★★★
PLXS has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Small / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Healthcare / Life SciencesManufacturing for surgical robotics, diagnostic systems, and life-critical patient monitoring devices.This is a stable, high-margin sector with long-term client commitments.
Industrial / CommercialHardware for automation, environmental monitoring, and smart facility management.Highly sensitive to macroeconomic industrial capital expenditure trends.
Aerospace / DefenseHighly reliable electronic components for defense and aerospace platforms.Provides long-term project visibility but requires stringent government compliance.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-10-28
When After Market
Estimate 2.26
Actual 2.51

Profitability

Profit Margin 4.08%
Operating Margin (TTM) 5.31%

Management Effectiveness

Return on Assets (TTM) 4.66%
Return on Equity (TTM) 13.38%

Valuation

Trailing PE 28.13
Forward PE 19.49
Enterprise Value 5.55B
Price to Sales(TTM) 1.12
Enterprise Value 5.55B
Price to Sales(TTM) 1.12
Enterprise Value to Revenue 1.12
Enterprise Value to EBITDA 16.42
Shares Outstanding 26.65M
Shares Floating 26.25M
Shares Outstanding 26.65M
Shares Floating 26.25M
Percent Insiders 1.59
Percent Institutions 102.4

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.